Premium
Sodium‐glucose co‐transporter type‐2 inhibitors: is the message getting through?
Author(s) -
Charlesworth M.,
Feddy L.,
Wisely N.
Publication year - 2019
Publication title -
anaesthesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.839
H-Index - 117
eISSN - 1365-2044
pISSN - 0003-2409
DOI - 10.1111/anae.14619
Subject(s) - medicine , guideline , diabetic ketoacidosis , intensive care medicine , ketoacidosis , context (archaeology) , type 2 diabetes , type 2 diabetes mellitus , diabetes mellitus , canagliflozin , general surgery , type 1 diabetes , endocrinology , paleontology , pathology , biology